Literature DB >> 19015344

In vitro susceptibility of field isolates of Leishmania donovani to Miltefosine and amphotericin B: correlation with sodium antimony gluconate susceptibility and implications for treatment in areas of endemicity.

Dhiraj Kumar1, Arpita Kulshrestha, Ruchi Singh, Poonam Salotra.   

Abstract

Indian Leishmania donovani isolates (n = 19) from regional zones representing various levels of antimony resistance displayed significantly (P < 0.01) correlated results with respect to in vitro susceptibility to the antileishmanial drugs sodium antimony gluconate, amphotericin B, and Miltefosine, raising the possibility of cross-resistance mechanisms operating in the field isolates. The results of gene expression analysis of LdMT and LdRos3 were suggestive of alternate mechanisms of Miltefosine susceptibility in the isolates.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19015344      PMCID: PMC2630609          DOI: 10.1128/AAC.01233-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

Review 1.  Treatment of visceral leishmaniasis.

Authors:  S Sundar
Journal:  Med Microbiol Immunol       Date:  2001-11       Impact factor: 3.402

2.  Availability of miltefosine for the treatment of kala-azar in India.

Authors:  Shyam Sundar; Henry W Murray
Journal:  Bull World Health Organ       Date:  2005-06-24       Impact factor: 9.408

3.  Possibility of membrane modification as a mechanism of antimony resistance in Leishmania donovani.

Authors:  Hema Kothari; Pranav Kumar; Shyam Sundar; Neeloo Singh
Journal:  Parasitol Int       Date:  2006-12-12       Impact factor: 2.230

4.  Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani.

Authors:  R Lira; S Sundar; A Makharia; R Kenney; A Gam; E Saraiva; D Sacks
Journal:  J Infect Dis       Date:  1999-08       Impact factor: 5.226

5.  A proteomics screen implicates HSP83 and a small kinetoplastid calpain-related protein in drug resistance in Leishmania donovani clinical field isolates by modulating drug-induced programmed cell death.

Authors:  Baptiste Vergnes; Benjamin Gourbal; Isabelle Girard; Shyam Sundar; Jolyne Drummelsmith; Marc Ouellette
Journal:  Mol Cell Proteomics       Date:  2006-10-17       Impact factor: 5.911

6.  Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in in vitro and in vivo experimental models.

Authors:  Anuradha Dube; Nasib Singh; Shyam Sundar; Neeloo Singh
Journal:  Parasitol Res       Date:  2005-05-03       Impact factor: 2.289

7.  Effects of antimycotic azoles on growth and sterol biosynthesis of Leishmania promastigotes.

Authors:  D H Beach; L J Goad; G G Holz
Journal:  Mol Biochem Parasitol       Date:  1988-11       Impact factor: 1.759

8.  Sterols of Leishmania species. Implications for biosynthesis.

Authors:  L J Goad; G G Holz; D H Beach
Journal:  Mol Biochem Parasitol       Date:  1984-02       Impact factor: 1.759

9.  Lipids of Leishmania promastigotes.

Authors:  D H Beach; G G Holz; G E Anekwe
Journal:  J Parasitol       Date:  1979-04       Impact factor: 1.276

10.  Miltefosine in the treatment of leishmaniasis: Clinical evidence for informed clinical risk management.

Authors:  Shyam Sundar; Piero L Olliaro
Journal:  Ther Clin Risk Manag       Date:  2007-10       Impact factor: 2.423

View more
  40 in total

1.  Biomarkers of antimony resistance: need for expression analysis of multiple genes to distinguish resistance phenotype in clinical isolates of Leishmania donovani.

Authors:  Dhiraj Kumar; Ruchi Singh; Vasundhra Bhandari; Arpita Kulshrestha; Narendra Singh Negi; Poonam Salotra
Journal:  Parasitol Res       Date:  2012-07       Impact factor: 2.289

2.  In vitro susceptibility of Leishmania donovani to miltefosine in Indian visceral leishmaniasis.

Authors:  Vijay Kumar Prajapati; Smriti Sharma; Madhukar Rai; Bart Ostyn; Poonam Salotra; Manu Vanaerschot; Jean-Claude Dujardin; Shyam Sundar
Journal:  Am J Trop Med Hyg       Date:  2013-08-26       Impact factor: 2.345

3.  Validation of a simple resazurin-based promastigote assay for the routine monitoring of miltefosine susceptibility in clinical isolates of Leishmania donovani.

Authors:  Arpita Kulshrestha; Vasundhra Bhandari; Rupkatha Mukhopadhyay; V Ramesh; Shyam Sundar; Louis Maes; Jean Claude Dujardin; Syamal Roy; Poonam Salotra
Journal:  Parasitol Res       Date:  2012-12-13       Impact factor: 2.289

4.  Susceptibility to Miltefosine in Brazilian Clinical Isolates of Leishmania (Viannia) braziliensis.

Authors:  Caroline R Espada; Fatima Ribeiro-Dias; Miriam L Dorta; Ledice Inácia de Araújo Pereira; Edgar M de Carvalho; Paulo R Machado; Albert Schriefer; Jenicer K U Yokoyama-Yasunaka; Adriano C Coelho; Silvia R B Uliana
Journal:  Am J Trop Med Hyg       Date:  2017-04-06       Impact factor: 2.345

5.  Molecular Docking and in Vitro Antileishmanial Evaluation of Chromene-2-thione Analogues.

Authors:  Rajiv Kumar Verma; Vijay Kumar Prajapati; Girijesh Kumar Verma; Deblina Chakraborty; Shyam Sundar; Madhukar Rai; Vikash Kumar Dubey; Maya Shankar Singh
Journal:  ACS Med Chem Lett       Date:  2012-01-18       Impact factor: 4.345

6.  Synthesis, DNA binding and antileishmanial activity of low molecular weight bis-arylimidamides.

Authors:  Moloy Banerjee; Abdelbasset A Farahat; Arvind Kumar; Tanja Wenzler; Reto Brun; Manoj M Munde; W David Wilson; Xiaohua Zhu; Karl A Werbovetz; David W Boykin
Journal:  Eur J Med Chem       Date:  2012-07-14       Impact factor: 6.514

7.  Visceral and post-Kala-Azar dermal leishmaniasis isolates show significant difference in their in vitro drug susceptibility pattern.

Authors:  Jyotsna Mishra; Rentala Madhubala; Sarman Singh
Journal:  Parasitol Res       Date:  2012-12-18       Impact factor: 2.289

8.  Treatment of visceral leishmaniasis.

Authors:  E M Moore; D N Lockwood
Journal:  J Glob Infect Dis       Date:  2010-05

9.  Linking in vitro and in vivo survival of clinical Leishmania donovani strains.

Authors:  Manu Vanaerschot; Ilse Maes; Meriem Ouakad; Vanessa Adaui; Louis Maes; Simonne De Doncker; Suman Rijal; François Chappuis; Jean-Claude Dujardin; Saskia Decuypere
Journal:  PLoS One       Date:  2010-08-17       Impact factor: 3.240

10.  Metabolomics to unveil and understand phenotypic diversity between pathogen populations.

Authors:  Ruben t'Kindt; Richard A Scheltema; Andris Jankevics; Kirstyn Brunker; Suman Rijal; Jean-Claude Dujardin; Rainer Breitling; David G Watson; Graham H Coombs; Saskia Decuypere
Journal:  PLoS Negl Trop Dis       Date:  2010-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.